Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Stock Quote Today & Recent News MGM RESORTS INTERNATIONAL MGM

MGM Resorts is the largest resort operator on the Las Vegas Strip with 35,000 guest rooms and suites, representing about one fourth of all units in the market. The company's Vegas properties include MGM Grand, Mandalay Bay, Mirage, Luxor, New York-New York, and CityCenter. The Strip contributed approximately 49% of total EBITDAR in the prepandemic year of 2019. MGM also owns U.S. regional assets, which represented 29% of 2019 EBITDAR. We estimate MGM's U.S. sports and iGaming operations are currently a mid-single-digit percentage of its total revenue. The company also operates the 56%-owned MGM Macau casinos with a new property that opened on the Cotai Strip in early 2018. Further, we estimate MGM will open a resort in Japan in 2027.

The Power Play by The Market Herald
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Stock Price Chart (NYSE:MGM)

Fundamentals Snapshot (NYSE:MGM)

Opinion & Analysis (NYSE:MGM)

Casino ETF Keeps Landing On Red

Benzinga.com  September 17, 2014

Bullboard Posts (NYSE:MGM)

FSD Pharma Subsidiary Lucid Psycheceuticals Files for Patent

 
KarenCar - July 14, 2022

FSD Will Proceed with Phase2 of FSD-201 Soon After Clearance

<< View Post To Watch Video >> FSD Pharma ready to proceed with Phase 2 clinical trial of FSD-201 as soon as it gets...
KarenCar - June 3, 2022

FSD Pharma Files Investigational New Drug Application “IND”

KarenCar - June 1, 2022

FSD Pharma Closes CAD$16.4 Million Sale of Non-Core Assets

 
KarenCar - May 10, 2022

Lucid-MS for Multiple Sclerosis Treatment

<< View Post To Watch Video >>
KarenCar - May 3, 2022

"Julia Levy Award" Recipient David Allan and Dr. John McGraw

 
KarenCar - April 25, 2022